Adiposity and insulin sensitivity derived from intravenous glucose tolerance tests in antipsychotic-treated patients (Q79998509)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17375138%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Adiposity and insulin sensitivity derived from intravenous glucose tolerance tests in antipsychotic-treated patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17375138%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Dan W Haupt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17375138%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Peter A Fahnestock

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17375138%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Karen A Flavin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17375138%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Julie A Schweiger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17375138%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Angela Stevens

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17375138%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Martha J Hessler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17375138%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Justin Maeda

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17375138%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Michael Yingling

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17375138%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

John W Newcomer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17375138%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

21 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17375138%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17375138%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17375138%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17375138%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

2561-2569

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17375138%20AND%20SRC:MED&resulttype=core&format=json

Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements.

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Schizophrenia: a life-shortening disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

The distribution of body mass index among individuals with and without schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

The G972R variant of the insulin receptor substrate-1 (IRS-1) gene, body fat distribution and insulin-resistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Neuroendocrine abnormalities in visceral obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Cardiovascular risk factors for people with mental illness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

The association of medical comorbidity in schizophrenia with poor physical and mental health.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

A prospective analysis of the HOMA model. The Mexico City Diabetes Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Excess mortality of mental disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Differential metabolic effects of antipsychotic treatments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Determinants of smoking behaviour in outpatients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Genetics of type 2 diabetes and insulin resistance: knowledge from human studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Mortality and causes of death in schizophrenia in Stockholm county, Sweden

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Adiposity, fat distribution, and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Age and glucose intolerance: effect of fitness and fatness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

The metabolic syndrome: requiescat in pace

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Differential effects of BMI on diabetes risk among black and white Americans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Metabolic syndrome and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021

Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301392

7 January 2021